Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF 10A
NM
Basal B
Bortezomib
Proteasome
Proteasome
7484.074
uM
5.65780
26.0580
-0.7316 -1.0000 0.7193 0.3449
0.9770
2.6137
HCC2185
TNBC
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7464.084
uM
12.26940
52.37260
-0.9938 -1.0000 0.7570 0.5239
0.9749
0.8152
MDA-MB-361
HER2amp
Luminal
NSC 663284
CDC25
CDC
10643.14
uM
4.11240
5.87110
-1.0000 -1.0000 3.0857 0.5047
0.9986
0.5078
MDA-MB-175-VII
HR+
Luminal
Oxamflatin
HDAC
HDAC
10818.147
uM
1.67690
5.38280
-0.9992 -1.0000 0.9420 0.5055
0.9397
0.5138
HCC1187
TNBC
Basal A
GW843682X
PLK
PLK
10518.139
uM
9.37850
81.90440
0.2153 -1.0000 0.5069 0.1636
0.9748
1.2366
MDA-MB-175-VII
HR+
Luminal
LBH589
HDAC
HDAC
12126.154
uM
0.27124
0.50934
-0.9836 -1.0000 1.7435 0.7744
0.9444
0.6012
Hs 578T
TNBC
Basal B
AG1478
EGFR
ErbB
7861.016
uM
53.58820
340.84020
0.1558 -1.0000 0.5938 0.1756
0.8868
2.0473
MCF12A
NM
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
10061.12
uM
4.1260
26.98840
-0.7649 -1.0000 0.5850 0.5535
0.9255
2.0669
BT-474
HER2amp
Luminal
Nelfinavir
13125.174
uM
10.470
16.79570
-0.6639 -1.0000 2.3245 0.2049
0.9671
0.9685
MDA-MB-361
HER2amp
Luminal
Oxaliplatin
DNA cross-linker
DNA cross-linker
10095.021
uM
6.92450
24.19920
-0.9770 -1.0000 0.8780 0.5196
0.9683
0.9164
MDA-MB-134-VI
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
10519.142
uM
0.59501
3.20580
-0.9918 -1.0000 0.6523 0.6178
0.9514
0.8963
SUM159PT
TNBC
Basal B
Nelfinavir
13004.174
uM
9.96910
15.89760
-0.7031 -1.0000 2.3541 0.1857
0.9862
3.2757
184A1
NM
Basal
Temsirolimus
MTOR
MTOR
12509.168
uM
0.69862
4.34640
-0.9247 -1.0000 0.6010 0.6200
0.8824
1.3516
HCC1187
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7431.092
uM
17.99520
32.95840
-0.9544 -1.0000 1.8155 0.5021
0.9764
1.5006
HCC1187
TNBC
Basal A
Imatinib
ABL/KIT/PDGFR
nRTK
7432.091
uM
25.0250
34.86710
-0.9960 -1.0000 3.3124 0.4749
0.9875
1.0227
HCC1954
HER2amp
Basal A
PD184352
MEK
MAPK
11055.155
uM
23.75260
483.87240
0.4233 -1.0000 0.3645 0.1483
0.9484
1.7439
MDA-MB-175-VII
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
10818.072
uM
3.08970
143.59610
-0.2313 -1.0000 0.2862 0.4022
0.7539
0.4268
HCC2185
TNBC
Luminal
5-DFUR
TYMS
TYMS
10996.143
uM
124.03170
741.86030
-0.5992 -1.0000 0.6142 0.4500
0.8811
0.3034
BT-474
HER2amp
Luminal
NSC 663284
CDC25
CDC
12291.152
uM
1.41260
2.14060
-0.9965 -1.0000 2.6431 0.7780
0.9658
0.6792
MDA-MB-361
HER2amp
Luminal
GSK1070916
AURK
AURK
7896.001
uM
7.70880
10.54470
-0.9698 -1.0000 3.5070 0.1637
0.9943
1.1912
HMT-3522 S1
Unknown
Unknown
Topotecan
TOP1
TOP
7911.007
uM
27.23380
87.39960
-0.1449 -1.0000 0.9422 0.1736
0.9448
1.5549
MDA-MB-175-VII
HR+
Luminal
Nelfinavir
13754.174
uM
6.54890
9.60220
-0.9753 -1.0000 2.8707 0.3702
0.8599
0.4290
MCF12A
NM
Basal B
PD184352
MEK
MAPK
10817.155
uM
8.38830
73.96110
0.1203 -1.0000 0.5047 0.1828
0.8989
1.6045
MCF 10A
NM
Basal B
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11056.154
uM
1.11180
5.18750
-0.6144 -1.0000 0.7133 0.3656
0.9875
2.9341
SUM159PT
TNBC
Basal B
Oxamflatin
HDAC
HDAC
11057.147
uM
0.84250
4.57980
-0.7232 -1.0000 0.6489 0.4577
0.9988
3.9818